Live Breaking News & Updates on Tumor Microenvironment Activated Biologics

Stay updated with breaking news from Tumor microenvironment activated biologics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Short Interest in Sensei Biotherapeutics, Inc. (NASDAQ:SNSE) Increases By 250.6%

Sensei Biotherapeutics, Inc. (NASDAQ:SNSE – Get Free Report) saw a significant growth in short interest during the month of May. As of May 31st, there was short interest totalling 282,600 shares, a growth of 250.6% from the May 15th total of 80,600 shares. Based on an average daily volume of 250,600 shares, the short-interest ratio […] ....

Sensei Biotherapeutics , Sensei Biotherapeutics Inc , Sensei Biotherapeutics Company Profile , Get Free Report , Tumor Microenvironment Activated Biologics ,

Short Interest in Sensei Biotherapeutics, Inc. (NASDAQ:SNSE) Increases By 250.6%

Sensei Biotherapeutics, Inc. (NASDAQ:SNSE – Get Free Report) saw a significant growth in short interest during the month of May. As of May 31st, there was short interest totalling 282,600 shares, a growth of 250.6% from the May 15th total of 80,600 shares. Based on an average daily volume of 250,600 shares, the short-interest ratio […] ....

Sensei Biotherapeutics , Sensei Biotherapeutics Inc , Sensei Biotherapeutics Company Profile , Get Free Report , Tumor Microenvironment Activated Biologics ,

Sensei Biotherapeutics, Inc. (NASDAQ:SNSE) Sees Significant Increase in Short Interest

Sensei Biotherapeutics, Inc. (NASDAQ:SNSE – Get Free Report) saw a significant growth in short interest during the month of May. As of May 15th, there was short interest totalling 80,600 shares, a growth of 34.1% from the April 30th total of 60,100 shares. Currently, 0.5% of the company’s shares are sold short. Based on an […] ....

Sensei Biotherapeutics , Sensei Biotherapeutics Company Profile , Sensei Biotherapeutics Inc , Get Free Report , Tumor Microenvironment Activated Biologics ,

Sensei Biotherapeutics (NASDAQ:SNSE) Receives Overweight Rating from Stephens

Stephens reiterated their overweight rating on shares of Sensei Biotherapeutics (NASDAQ:SNSE – Free Report) in a research note issued to investors on Friday morning, Benzinga reports. They currently have a $5.00 price objective on the stock. Sensei Biotherapeutics Trading Down 45.5 % NASDAQ:SNSE opened at $0.79 on Friday. The company has a debt-to-equity ratio of […] ....

Sensei Biotherapeutics , Sensei Biotherapeutics Inc , Free Report , Get Free Report , Tumor Microenvironment Activated Biologics ,

Sensei Biotherapeutics (NASDAQ:SNSE) Given "Buy" Rating at HC Wainwright

Sensei Biotherapeutics (NASDAQ:SNSE) Given "Buy" Rating at HC Wainwright
dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.

Sensei Biotherapeutics , Sensei Biotherapeutics Company Profile , Sensei Biotherapeutics Inc , Free Report , Get Free Report , Tumor Microenvironment Activated Biologics ,